CHACKALAMANNIL SAMUEL has a total of 17 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LY TAI WEI, NEUROSEARCH AS and SANOFI AVENTIS DEUTCHLAND GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | United States | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chackalamannil Samuel | 17 |
#2 | Xia Yan | 12 |
#3 | Chelliah Mariappan V | 11 |
#4 | Wang Yuguang | 7 |
#5 | Clasby Martin C | 6 |
#6 | Greenlee William J | 4 |
#7 | Eagen Keith A | 3 |
#8 | Gao Xiaobang | 2 |
#9 | Chan Tin-Yau | 2 |
#10 | Mckittrick Brian | 1 |
Publication | Filing date | Title |
---|---|---|
US2011135650A1 | Morpholinone compounds as factor IXA inhibitors | |
WO2009124103A2 | Combination therapies comprising par1 antagonists with par4 antagonists | |
WO2007123949A2 | Cannabinoid receptor modulators |